Proteolysis targeting chimera ( PROTAC ) for epidermal growth factor receptor enhances anti‐tumor immunity in non‐small cell lung cancer
出版年份 2020 全文链接
标题
Proteolysis targeting chimera (
PROTAC
) for epidermal growth factor receptor enhances anti‐tumor immunity in non‐small cell lung cancer
作者
关键词
-
出版物
DRUG DEVELOPMENT RESEARCH
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-11-25
DOI
10.1002/ddr.21765
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- Phase 1 Study of Epacadostat in Combination With Atezolizumab for Patients With Previously Treated Advanced Non‐Small Cell Lung Cancer
- (2020) Matthew D. Hellmann et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders
- (2020) Meng Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- T Cell Dysfunction and Exhaustion in Cancer
- (2020) Zhen Zhang et al. Frontiers in Cell and Developmental Biology
- Discovery and biological evaluation of proteolysis targeting chimeras (PROTACs) as an EGFR degraders based on osimertinib and lenalidomide
- (2020) Kailun He et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Proteolysis targeting chimeras (PROTACs) for epigenetics research
- (2020) Anja Vogelmann et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Epidermal Growth Factor Receptor-responsive indoleamine 2, 3 dioxygenase confers immune homeostasis during S. flexneri infection
- (2019) Tanushree Mukherjee et al. JOURNAL OF INFECTIOUS DISEASES
- Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
- (2019) D. Ross Camidge et al. Nature Reviews Clinical Oncology
- Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors
- (2019) Kyung Hae Jung et al. CLINICAL CANCER RESEARCH
- Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
- (2019) Anqi Lin et al. Molecular Cancer
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- Targeted protein degradation: expanding the toolbox
- (2019) Matthieu Schapira et al. NATURE REVIEWS DRUG DISCOVERY
- Indoleamine-2,3-Dioxygenase in Non–Small Cell Lung Cancer
- (2018) Ashley Volaric et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- IDO1 in cancer: a Gemini of immune checkpoints
- (2018) Lijie Zhai et al. Cellular & Molecular Immunology
- Combination Immunotherapy in Non-small Cell Lung Cancer
- (2018) Melina E. Marmarelis et al. Current Oncology Reports
- Acute Pharmacologic Degradation of a Stable Antigen Enhances Its Direct Presentation on MHC Class I Molecules
- (2018) Sarah C. Moser et al. Frontiers in Immunology
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Specific MHC-I Peptides Are Induced Using PROTACs
- (2018) Stephanie M. Jensen et al. Frontiers in Immunology
- Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis
- (2017) Chee Khoon Lee et al. Journal of Thoracic Oncology
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB
- (2015) Kailong Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
- (2013) E. A. Akbay et al. Cancer Discovery
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now